Anaplasmosis (Anaplasma phagocytophilum)

Overview


Plain-Language Overview

Anaplasmosis is an infection caused by the bacterium Anaplasma phagocytophilum that primarily affects the blood and immune system. It is transmitted to humans through the bite of infected black-legged ticks. The infection mainly targets white blood cells, leading to symptoms such as fever, chills, muscle aches, and fatigue. Because it affects the immune cells, it can weaken the body's ability to fight infections. If untreated, it can cause more severe complications, especially in older adults or those with weakened immune systems. Early recognition is important to prevent serious illness.

Clinical Definition

Anaplasmosis is an acute febrile illness caused by the obligate intracellular bacterium Anaplasma phagocytophilum, which infects neutrophils. It is transmitted by the bite of infected Ixodes ticks, primarily Ixodes scapularis in the United States. The pathogen invades and replicates within neutrophils, leading to immune dysregulation and systemic inflammation. Clinically, it presents with fever, myalgia, headache, and sometimes leukopenia and thrombocytopenia. The disease is significant due to its potential for severe complications such as respiratory failure, organ dysfunction, and death if untreated. Diagnosis and treatment are critical to reduce morbidity, especially in endemic areas.

Inciting Event

  • Bite from an infected Ixodes scapularis or Ixodes pacificus tick transmits Anaplasma phagocytophilum.

  • Tick attachment for >24 hours is typically required for transmission of the pathogen.

Latency Period

  • Incubation period of 1-2 weeks after tick bite before symptom onset.

  • Symptoms typically develop within 5-14 days post-exposure.

Diagnostic Delay

  • Nonspecific early symptoms such as fever and malaise mimic viral illnesses, leading to misdiagnosis.

  • Lack of awareness in non-endemic areas delays consideration of anaplasmosis.

  • Negative initial serologies early in disease course can delay diagnosis.

  • Overlap with other tick-borne diseases such as Lyme disease complicates clinical recognition.

Clinical Presentation


Signs & Symptoms

  • Acute onset fever, chills, and malaise are hallmark symptoms.

  • Myalgias and arthralgias are common systemic complaints.

  • Headache is frequently reported and can be severe.

  • Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain occur in many patients.

  • Cough and mild respiratory symptoms may be present.

History of Present Illness

  • Acute onset of high fever, chills, and headache typically marks initial presentation.

  • Myalgias and malaise develop early and are prominent symptoms.

  • Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur.

  • Cough and respiratory symptoms can be present but are less common.

  • Symptoms progress over several days without treatment, potentially leading to severe complications.

Past Medical History

  • Prior tick bites or tick-borne infections increase suspicion for anaplasmosis.

  • Immunosuppressive conditions or therapies may worsen disease severity.

  • Chronic illnesses such as diabetes or chronic kidney disease can complicate clinical course.

Family History

  • []

Physical Exam Findings

  • Fever is the most consistent physical finding in anaplasmosis.

  • Tachycardia and tachypnea may be present due to systemic infection.

  • Hepatosplenomegaly can be observed in some cases due to immune activation.

  • Lymphadenopathy is typically absent or mild, helping differentiate from other tick-borne illnesses.

  • Rash is uncommon, which helps distinguish anaplasmosis from ehrlichiosis or Rocky Mountain spotted fever.

Diagnostic Workup


Diagnostic Criteria

Diagnosis of anaplasmosis is established by a combination of clinical presentation with fever and leukopenia in a patient with potential tick exposure, supported by laboratory findings of morulae within neutrophils on peripheral blood smear. Confirmation is achieved through polymerase chain reaction (PCR) testing for Anaplasma phagocytophilum DNA or by a fourfold rise in specific antibody titers using indirect immunofluorescence assay (IFA). Early diagnosis relies heavily on clinical suspicion and laboratory evidence of infection.

Pathophysiology


Key Mechanisms

  • Intracellular infection of neutrophils by Anaplasma phagocytophilum leads to impaired neutrophil function and immune evasion.

  • Phagosome maturation inhibition prevents bacterial killing and allows replication within neutrophils.

  • Cytokine release triggered by infected neutrophils causes systemic inflammatory response and clinical symptoms.

  • Leukopenia and thrombocytopenia result from bone marrow suppression and peripheral destruction during infection.

InvolvementDetails
Organs

Spleen is involved in immune clearance and may be enlarged due to systemic infection.

Liver function can be transiently impaired, reflected by mild transaminase elevations during infection.

Tissues

Endothelial tissue is affected indirectly through systemic inflammation and vascular permeability changes.

Cells

Neutrophils are the primary host cells infected by Anaplasma phagocytophilum, leading to impaired immune function.

Monocytes may also be involved in the immune response and contribute to systemic inflammation.

Chemical Mediators

Cytokines such as tumor necrosis factor-alpha and interleukin-6 are elevated, mediating systemic inflammatory symptoms.

Interferon-gamma plays a role in activating macrophages to control intracellular infection.

Treatments


Pharmacological Treatments

  • Doxycycline

    • Mechanism:
      • Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit of Anaplasma phagocytophilum.

    • Side effects:
      • Photosensitivity

      • Gastrointestinal upset

      • Tooth discoloration in children

    • Clinical role:
      • First-line

Non-pharmacological Treatments

  • Supportive care including hydration and antipyretics to manage fever and malaise.

Prevention


Pharmacological Prevention

  • Doxycycline prophylaxis after high-risk tick exposure can prevent anaplasmosis.

  • No vaccine is currently available for anaplasmosis prevention.

Non-pharmacological Prevention

  • Avoidance of tick-infested areas during peak seasons reduces risk.

  • Use of insect repellents containing DEET on skin and permethrin on clothing is effective.

  • Prompt tick removal within 24 hours decreases transmission likelihood.

  • Wearing protective clothing such as long sleeves and pants in endemic areas helps prevent bites.

Outcome & Complications


Complications

  • Respiratory failure due to acute respiratory distress syndrome (ARDS) can occur in severe cases.

  • Secondary bacterial infections may develop due to immune dysregulation.

  • Hemophagocytic lymphohistiocytosis (HLH) is a rare but serious immune complication.

  • Neurologic complications such as meningoencephalitis can develop.

Short-term Sequelae Long-term Sequelae
  • Prolonged fever and systemic symptoms lasting weeks despite treatment.

  • Transient cytopenias including anemia, thrombocytopenia, and leukopenia.

  • Elevated liver enzymes may persist for several weeks post-infection.

  • Fatigue and malaise can continue during convalescence.

  • Most patients recover fully without chronic sequelae.

  • Post-infectious fatigue syndrome may rarely persist for months.

  • No evidence of chronic infection or organ damage after appropriate treatment.

Differential Diagnoses


Anaplasmosis (Anaplasma phagocytophilum) versus Lyme Disease

Anaplasmosis (Anaplasma phagocytophilum)

Lyme Disease

Tick bite in wooded areas with exposure to Ixodes ticks carrying Anaplasma phagocytophilum

Tick bite in wooded areas with exposure to Ixodes ticks carrying Borrelia burgdorferi

Detection of morulae in granulocytes or positive PCR for Anaplasma phagocytophilum

Positive serology for Borrelia burgdorferi antibodies

Fever, headache, myalgias without rash, often with leukopenia and thrombocytopenia

Erythema migrans rash and later arthritis or neurologic symptoms

Anaplasmosis (Anaplasma phagocytophilum) versus Babesiosis

Anaplasmosis (Anaplasma phagocytophilum)

Babesiosis

Intracytoplasmic morulae in granulocytes from Anaplasma phagocytophilum

Intraerythrocytic ring forms on blood smear from Babesia species

Leukopenia and thrombocytopenia without hemolysis

Hemolytic anemia with elevated lactate dehydrogenase and low haptoglobin

Responds to doxycycline

Responds to atovaquone plus azithromycin

Anaplasmosis (Anaplasma phagocytophilum) versus Rocky Mountain Spotted Fever

Anaplasmosis (Anaplasma phagocytophilum)

Rocky Mountain Spotted Fever

Tick bite from Ixodes species in endemic areas

Tick bite from Dermacentor species in endemic areas

Fever without rash or with nonspecific rash

Fever with characteristic petechial rash starting on wrists and ankles

PCR or blood smear positive for Anaplasma phagocytophilum

Serology or PCR positive for Rickettsia rickettsii

Anaplasmosis (Anaplasma phagocytophilum) versus Viral Febrile Illness (e.g., Influenza)

Anaplasmosis (Anaplasma phagocytophilum)

Viral Febrile Illness (e.g., Influenza)

Leukopenia with left shift

Normal or elevated white blood cell count

Gradual onset of fever, headache, and myalgias with prolonged course

Abrupt onset of fever, cough, and myalgias with rapid resolution

Improves with doxycycline

Improves with antiviral agents like oseltamivir

Anaplasmosis (Anaplasma phagocytophilum) versus Leptospirosis

Anaplasmosis (Anaplasma phagocytophilum)

Leptospirosis

Exposure to tick bite in endemic areas

Exposure to contaminated water or animal urine

Leukopenia and thrombocytopenia without significant jaundice

Elevated bilirubin and renal dysfunction with mild leukocytosis

Monophasic febrile illness

Biphasic illness with initial septicemic phase followed by immune phase

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.